Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of PTEN loss in cancer: It’s all about diversity
Virginia Álvarez-García, Yasmine Tawil, Helen Wise, et al.
Seminars in Cancer Biology (2019) Vol. 59, pp. 66-79
Closed Access | Times Cited: 333

Showing 1-25 of 333 citing articles:

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Ali S. Alzahrani
Seminars in Cancer Biology (2019) Vol. 59, pp. 125-132
Closed Access | Times Cited: 858
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Olga Kardymon, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-17
Open Access | Times Cited: 735
The role of collagen in cancer: from bench to bedside
Shuaishuai Xu, Huaxiang Xu, Wenquan Wang, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 631
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang, Qijie Dai, Xiaorui Su, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 6, pp. 4587-4629
Open Access | Times Cited: 469
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Le Yu, Jessica Wei, Pengda Liu
Seminars in Cancer Biology (2021) Vol. 85, pp. 69-94
Closed Access | Times Cited: 385
Oral squamous cell carcinomas: state of the field and emerging directions
Yunhan Tan, Zhihan Wang, Mengtong Xu, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 250
Mutational drivers of cancer cell migration and invasion
Nikita M. Novikov, Sofia Y. Zolotaryova, Alexis Gautreau, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 102-114
Open Access | Times Cited: 200
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 118
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 109
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 95
Molecular and functional imaging in cancer-targeted therapy: current applications and future directions
Jing‐Wen Bai, Si-Qi Qiu, Guo‐Jun Zhang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 93
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Teizo Yoshimura, Chunning Li, Yuze Wang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 714-738
Open Access | Times Cited: 50
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 39
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
Iseult Browne, Fabrice André, Sarat Chandarlapaty, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 4, pp. e139-e151
Closed Access | Times Cited: 31
Role of exosomal miRNAs and macrophage polarization in gastric cancer: a novel therapeutic strategy
Yun Zhang, Baozhen Wang, Jing Chen, et al.
European Journal of Pharmacology (2025), pp. 177268-177268
Closed Access | Times Cited: 2
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 719-719
Open Access | Times Cited: 117
Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
Eva Coll-de la Rubia, Elena Martinez‐Garcia, Gunnar Dittmar, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1900-1900
Open Access | Times Cited: 98
Modulation of the tumor microenvironment (TME) by melatonin
Mu Qi, Masoud Najafi
European Journal of Pharmacology (2021) Vol. 907, pp. 174365-174365
Closed Access | Times Cited: 68
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Wentao Zeng, Xiaohang Long, Pu‐Ste Liu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 918-931
Closed Access | Times Cited: 37
The ER-mitochondria interface, where Ca2+ and cell death meet
Ian de Ridder, Martijn Kerkhofs, Fernanda O. Lemos, et al.
Cell Calcium (2023) Vol. 112, pp. 102743-102743
Open Access | Times Cited: 34
YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer
Yinjie Su, Bo Wang, Jian Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 7
Open Access | Times Cited: 29
Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome
Thiago Vidotto, Camila Morais Melo, William Lautert-Dutra, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188904-188904
Closed Access | Times Cited: 26
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 23
Correlation of PTEN signaling pathway and miRNA in breast cancer
Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top